EXEL - Intrinsic Value and Financial Analysis - Exelixis, Inc.

Exelixis, Inc. EXEL

Healthcare - Biotechnology - NASDAQ - US

Watchlist

$ 34.45

-1.71 %

$ 9.84 B

Market Cap

22.23

P/E

BALANCE SHEET

2.94 B ASSETS

Growth Rates

1Year -4.20%

3Years 11.24%

5Years 15.65%

7Years 25.58%

10Years 19.31%

678 M LIABILITIES

Growth Rates

1Year 16.36%

3Years 37.99%

5Years 38.15%

7Years 4.21%

10Years 4.50%

2.26 B EQUITY

Growth Rates

1Year -9.02%

3Years 6.41%

5Years 11.95%

7Years 58.69%

10Years 42.36%

BALANCE SHEET DECOMPOSITION

Balance Sheet Decomposition Exelixis, Inc.

2.94 B ASSETS
678 M LIABILITIES

Current Assets	1.32 B
Cash & Short-Term Investments	995 M
Receivables	237 M
Other Current Assets	85.2 M
Non-Current Assets	1.62 B
Long-Term Investments	729 M
PP&E	471 M
Other Non-Current Assets	425 M

Current Liabilities	394 M
Accounts Payable	33.8 M
Short-Term Debt	0
Other Current Liabilities	361 M
Non-Current Liabilities	284 M
Long-Term Debt	190 M
Other Non-Current Liabilities	94.2 M

Balance Sheet

Millions

	Dec-2023	Dec-2022	Dec-2021	Jan-2021	Jan-2020	Dec-2018	Dec-2017	Dec-2016	Jan-2016	Dec-2014	Dec-2013	Dec-2012	Dec-2011	Dec-2010	Jan-2010	Jan-2009	Dec-2007	Dec-2006	Dec-2005	Dec-2004	Dec-2003	Dec-2002	Dec-2001	Dec-2000	Dec-1999	Dec-1998
ASSETS
Cash & Cash Equivalents	263.0	501.2	647.2	319.2	266.5	314.8	183.2	151.7	141.6	80.4	104.0	170.1	74.3	97.4	86.8	247.7	135.5	123.4	96.5	78.1	111.8	84.5	35.6	19.6	5.4	0
Short Term Investments	732.3	807.3	819.9	887.3	585.7	378.6	204.6	268.1	25.4	63.9	138.5	241.4	120.0	65.2	116.3	14.7	136.1	55.5	67.3	77.1	125.3	131.7	192.1	93.0	1.5	0
Receivables	237.4	214.8	282.6	160.9	119.1	178.8	81.2	40.4	5.2	4.9	3.9	2.8	30.2	5.9	11.9	1.5	6.1	22.2	7.1	4.4	3.8	3.3	4.0	1.5	0.2	0
Inventory	17.3	33.3	27.5	21.0	12.9	9.8	6.7	3.3	2.6	2.4	2.9	1	0	0	0	13 K	51 K	6.1	5.4	0	0	0	0	3.6	0	0
Other Current Assets	67.9	62.2	57.5	57.0	27.0	46.1	9.3	5.4	3.8	15.7	17.3	18.4	8.7	29.9	30.1	7.7	6.2	61.2	39.5	8.7	3.2	3.8	2.9	2.0	0.9	0
Total Current Assets	1 318.0	1 618.8	1 834.7	1 445.4	1 011.2	897.0	484.9	470.8	178.7	167.2	266.6	432.5	228.8	183.5	230.0	271.6	283.8	262.3	210.4	164.0	244.1	223.4	234.6	119.6	8.0	0
PP&E	470.9	401.2	104.0	67.4	90.7	56.8	25.7	2.1	1.4	2.4	4.9	6.1	8.5	15.8	29.4	36.2	34.7	32.3	35.6	35.5	33.5	32.4	36.5	23.5	9.5	0
Intangible Assets	0	0	0	0	0	0	0	0	63.7	0	0	0	0	0	0	0	0	2.6	70.8	71.9	71.5	72.2	69.5	58.7	0	0
Goodwill	63.7	63.7	63.7	63.7	63.7	63.7	63.7	63.7	63.7	63.7	63.7	63.7	63.7	63.7	63.7	63.7	63.7	67.4	67.4	67.4	67.4	0	0	0	0	0
Long Term Investments	728.7	756.7	371.1	332.3	536.4	157.2	64.3	55.6	83.6	81.6	144.3	182.3	89.5	93.7	17.9	17.8	20.7	19.6	15.0	0	0	0	0	0	0	0
Other Long Term Assets	0	0	131.0	71.9	11.3	3.5	16.7	5.4	5.0	13.0	23.8	36.5	2.8	4.1	2.4	30.1	30.0	30.9	16.0	20.0	8.7	11.1	6.0	3.1	1.4	0
Other Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	2 942.4	3 071.5	2 616.2	2 137.3	1 885.7	1 422.3	655.3	597.5	332.3	328.0	503.3	721.1	393.3	360.8	343.4	401.6	412.1	395.4	332.7	291.3	357.8	339.1	346.6	204.9	18.9	9.0
LIABILITIES
Accounts Payable	33.8	32.7	24.3	23.6	11.6	10.9	9.6	6.6	6.4	6.4	9.3	4.4	2.0	2.0	7.4	4.9	9.3	3.7	1.7	5.9	6.2	4.7	10.8	10.1	3.6	0
Short Term Debt	0	0	0	0	2.7	2.7	0	189.1	0	99.3	11.8	13.2	4.9	37.7	39.3	43.0	15.8	13.6	42.0	10.9	9.9	8.7	7.1	7.0	2.3	0
Other Current Liabilities	360.5	284.2	305.5	179.2	128.4	91.8	73.6	53.4	45.9	63.6	65.3	47.8	43.6	59.9	57.1	52.7	43.7	30.7	21.6	18.3	16.5	13.1	10.1	7.1	2.8	0
Total Current Liabilities	394.3	324.4	337.6	204.7	142.7	105.5	115.2	270.6	52.3	171.9	87.9	81.7	92.3	199.9	207.1	189.5	132.9	111.4	108.8	63.8	54.1	50.2	40.4	24.1	8.7	0
Long Term Debt	189.9	190.2	51.3	49.1	48.0	12.2	14.5	0	417.9	262.4	335.5	322.6	176.6	170.7	40.4	74.7	105.7	108.1	106.9	136.5	101.2	65.3	41.8	8.0	11.0	0
Deferred Tax Income	0	0	0	10.2	9.2	1.3	(14.5)	0	0	0	0	0	0	0	0	(171.0)	(63.1)	(64.8)	(45.3)	(32.4)	(39.8)	0	0	0	0	0
Other Liabilities	94.2	62.0	8.0	0.7	2.3	1.3	2.1	0.5	3.0	8.5	13.7	20.4	17.3	16.0	17.3	22.6	24.9	20.5	14.5	8.0	41.0	47.7	27.2	9.0	2.0	0
Total Liabilities	678.4	583.1	405.6	258.2	199.7	134.8	370.3	508.2	436.6	442.8	437.0	424.7	302.6	589.1	507.1	457.9	326.6	304.8	275.4	240.7	196.3	163.2	109.4	41.1	21.7	0
EQUITY
Common Stock	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	96 K	84 K	75 K	71 K	59 K	56 K	47 K	19.5	0
Retained Earnings	(173.4)	(34.2)	(216.5)	(447.6)	(559.4)	(880.4)	(1 829.2)	(1 983.1)	(1 937.0)	(1 767.3)	(1 498.8)	(1 254.0)	(1 106.4)	(1 182.1)	(1 089.7)	(954.5)	(791.6)	(705.3)	(603.8)	(519.4)	(382.1)	(287.4)	(201.2)	(130.0)	(54.7)	(36.0)
Other Accumulative Comprehensive Income/Loss	(3.8)	(14.5)	(0.8)	4.5	3.1	(0.7)	(0.3)	(0.4)	(0.2)	(0.1)	0.1	92 K	(0.1)	12 K	0.2	(93.7)	0.5	1.1	1.0	0.6	1.6	(0.5)	(5.8)	(11.6)	(14.4)	0
Total Equity	2 263.9	2 488.4	2 210.6	1 879.1	1 686.0	1 287.5	285.0	89.3	(104.3)	(114.8)	66.2	296.4	90.6	(228.3)	(163.7)	(56.3)	85.5	90.6	57.3	50.7	161.5	175.9	237.2	163.8	(2.8)	(35.1)
Total Liabilities and Equity	2 942.4	3 071.5	2 616.2	2 137.3	1 885.7	1 422.3	655.3	597.5	332.3	328.0	503.3	721.1	393.3	360.8	343.4	401.6	412.1	395.4	332.7	291.3	357.8	339.1	346.6	204.9	18.9	9.0
SHARES OUTSTANDING
Common Shares Outstanding	318.2	321.5	314.9	308.3	302.6	297.9	293.6	250.5	209.2	194.3	184.0	160.1	126.0	108.5	107.1	105.5	99.1	86.6	78.8	72.5	65.4	56.6	46.5	31.0	4.1	2.0

Balance Sheet

Premium Plan

Unlimited Plan